ENDOCYTE INC License Agreements
9 Contracts & Agreements
- Amendments #9 and #10 to the Master License Agreement effective July 1, 2013 between Endocyte, Inc. and Purdue Research Foundation, as amended (Filed With SEC on February 27, 2018)
- Amendment #3 to the Exclusive License Agreement effective March 1, 2010 between Endocyte, Inc. and Purdue Research Foundation, as amended (Filed With SEC on February 27, 2018)
- Amendment #20 to the Amended and Restated Exclusive License Agreement dated October 21, 1998 between Endocyte, Inc. and Purdue Research Foundation, as amended (Filed With SEC on February 27, 2018)
- AMENDMENT #1 TO LICENSE AGREEMENT ID 2014-0052 Between Purdue Research Foundation and Endocyte, Inc. (Filed With SEC on May 10, 2017)
- Second Amendment to the Amended and Restated License Agreement made effective on March 1, 2010 between the Purdue Research Foundation and Endocyte, Inc. (“Agreement”) (Filed With SEC on May 10, 2017)
- AMENDMENT #14 TO LICENSE AGREEMENT ID LA0003Endocyte Between Purdue Research Foundation and Endocyte Corporation (Filed With SEC on May 10, 2017)
- MASTER LICENSE AGREEMENT Between PURDUE RESEARCH FOUNDATION and ENDOCYTE, INC. TABLE OF CONTENTS (Filed With SEC on March 13, 2015)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on August 8, 2014)
- LICENSE AGREEMENT BETWEEN ENDOCYTE, INC AND PURDUE RESEARCH FOUNDATION OCTOBER 21, 1998 (Filed With SEC on August 8, 2014)
